Toxicological assessment of kretek cigarettes: Part 1: Background, assessment approach, and summary of findings

Regulatory Toxicology and Pharmacology

Volumn 70, Issue S1, 2014, Pages S2-S14

  Roemer, E ^a   Dempsey, R ^a   Schorp, M K ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

Author keywords

Clove cigarettes; Cytotoxicity; Eugenol; Ingredients; Inhalation toxicity; Kretek cigarettes; Mutagenicity; Smoke chemistry

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CLOVE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GENOTOXICITY; HEALTH HAZARD; IN VITRO STUDY; IN VIVO STUDY; KRETEK CIGARETTE; MALE; MUTAGENICITY; NONHUMAN; PARTICULATE MATTER; PNEUMONIA; RAT; SMOKE; SMOKING; SOCIOECONOMICS; TOBACCO; TOXICOLOGY; ADVERSE EFFECTS; ANIMAL; EUGENIA; HUMAN; TOXICITY; TOXICITY TESTING;

NICOTIANA TABACUM; SYZYGIUM AROMATICUM;

SMOKE;

ANIMALS; EUGENIA; HUMANS; SMOKE; TOBACCO PRODUCTS; TOXICITY TESTS;

EID: 84919732756     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2014.11.015     Document Type: Article

References (116)

1. American Medical Association, Council on Scientific Affairs Evaluation of the health hazard of clove cigarettes. JAMA 1988, 260:3641-3644.
2. Anderson I. Deaths follow U.S. craze for clove cigarettes. New Sci. 1985, 105:7.
3. Arnez M. Tobacco and Kretek: Indonesian Drugs in Historical Change. J. Southeast Asian Stud. 2009, 2:49-69.
4. Ashley, D.L., Burns, D., Djordjevic, M., Dybing, E., Gray, N., Hammond, S.K., Henningfield, J., Jarvis, M., Reddy, K.S., Robertson, C., Zaatari, G., 2008. The scientific basis of tobacco product regulation. World Health Organ Tech Rep Ser 1-277, 271 pp. following 277.
5. Association for Assessment and Accreditation of Laboratory Animal Care International Guide to the Care and use of Laboratory Animals 2006, AAALAC, Frederick, MD, USA.
6. Azizan A., Blevins R.D. Mutagenicity and antimutagenicity testing of six chemicals associated with the pungent properties of specific spices as revealed by the Ames Salmonella/microsomal assay. Arch. Environ. Contam. Toxicol. 1995, 28:248-258.
7. Bean C.L., Armstrong M.J., Galloway S.M. Effect of sampling time on chromosome aberration yield for 7 chemicals in Chinese hamster ovary cells. Mutat. Res. 1992, 265:31-44.
8. Bean C.L., Galloway S.M. Evaluation of the need for a late harvest time in the assay for chromosome aberrations in Chinese hamster ovary cells. Mutat. Res. 1993, 292:3-16.
9. Bernstein L., Kaldor J., McCann J., Pike M.C. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat. Res. 1982, 97:267-281.
10. Borenfreund E., Puerner J.A. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 1985, 24:119-124.
11. Borenfreund E., Puerner J.A. Short-term quantitative in vitro cytotoxicity assay involving an S-9 activating system. Cancer Lett. 1987, 34:243-248.
12. Borm P.J., Jetten M., Hidayat S., van de Burgh N., Leunissen P., Kant I., Houba R., Soeprapto H. Respiratory symptoms, lung function, and nasal cellularity in Indonesian wood workers: a dose-response analysis. Occup. Environ. Med. 2002, 59:338-344.
13. Brodin P. Differential inhibition of A, B and C fibres in the rat vagus nerve by lidocaine, eugenol and formaldehyde. Arch. Oral Biol. 1985, 30:477-480.
14. Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 1: cigarette design, testing approach, and review of results. Food Chem. Toxicol. 2002, 40:77-91.
15. Carmines E.L., Lemus R., Gaworski C.L. Toxicologic evaluation of licorice extract as a cigarette ingredient. Food Chem. Toxicol. 2005, 43:1303-1322.
16. CDC Illnesses possibly associated with smoking clove cigarettes. MMWR Morb. Mortal. Wkly Rep. 1985, 34:297-299.
17. CDC, 2014. Bidis and kreteks. Available at http://www.cdc.gov/tobacco/data_statistics/fact_sheets/tobacco_industry/bidis_kreteks/.
18. Chaieb K., Hajlaoui H., Zmantar T., Kahla-Nakbi A.B., Rouabhia M., Mahdouani K., Bakhrouf A. The chemical composition and biological activity of clove essential oil, Eugenia caryophyllata (Syzigium aromaticum L. Myrtaceae): a short review. Phytother. Res. 2007, 21:501-506.
19. Clark G.C., et al. Toxicity studies on clove cigarette smoke and constituents of clove: determination of the LD50 of eugenol by intratracheal instillation in rats and hamsters by LaVoie. Arch. Toxicol. 1986, 59:296-299.
20. Clark G.C. Acute inhalation toxicity of eugenol in rats. Arch. Toxicol. 1988, 62:381-386.
21. Clark G.C. Comparison of the inhalation toxicity of kretek (clove cigarette) smoke with that of American cigarette smoke. I. One day exposure. Arch. Toxicol. 1989, 63:1-6.
22. Clark G.C. Comparison of the inhalation toxicity of kretek (clove cigarette) smoke with that of American cigarette smoke. II. Fourteen days, exposure. Arch. Toxicol. 1990, 64:515-521.
23. Clive D., Flamm W.G., Machesko M.R., Bernheim N.J. A mutational assay system using the thymidine kinase locus in mouse lymphoma cells. Mutat. Res. 1972, 16:77-87.
24. Cole J., Muriel W.J., Bridges B.A. The mutagenicity of sodium fluoride to L5178Y [wild-type and TK+/- (3.7.2c)] mouse lymphoma cells. Mutagenesis 1986, 1:157-167.
25. Counts M.E., Hsu F.S., Tewes F.J. Development of a commercial cigarette "market map" comparison methodology for evaluating new or non-conventional cigarettes. Regul. Toxicol. Pharmacol. 2006, 46:225-242.
26. CSA Evaluation of the health hazard of clove cigarettes. Council on Scientific Affairs. JAMA 1988, 260:3641-3644.
27. Dallmeier K., Carlini E.A. Anesthetic, hypothermic, myorelaxant and anticonvulsant effects of synthetic eugenol derivatives and natural analogues. Pharmacology 1981, 22:113-127.
28. Dempsey R., Coggins C.R., Roemer E. Toxicological assessment of cigarette ingredients. Regul. Toxicol. Pharmacol. 2011, 61:119-128.
29. Diekmann J., Wittig A., Stabbert R. Gas chromatographic-mass spectrometric analysis of acrylamide and acetamide in cigarette mainstream smoke after on-column injection. J. Chromatogr. Sci. 2008, 46:659-663.
30. Din German Institute for Standardization, DIN Technical Report 133, Toxicological Evaluation of Additives for Tobacco Products - A Guide 2014, Beuth Verlag, Berlin, (second revised version 2014, in press).
31. Djutaharta T., Surya H.V. Research on Tobacco in Indonesia: an Annotated Bibliography and Review of Research on Tobacco Use, Health Effects, Economics, and Control Efforts Health Nutrition and Population (HNP) Discussion Paper 2003, The World Bank, Wahington, DC, Available at
32. Dungworth D.L., Schwartz L.W., Tyler W.S. Morphological methods for evaluation of pulmonary toxicity in animals. Annu. Rev. Pharmacol. Toxicol. 1976, 16:381-399.
33. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 1955, 50:1096-1121.
34. FDA, 2009. Enforcement of General Tobacco Standard Special Rule for Cigarettes (available at In: [Docket No FDA-2009-N-0449]. http://www.gpo.gov/fdsys/pkg/FR-2009-09-25/html/E9-23144.htm.
35. Friedrichs B., Miert E., Vanscheeuwijck P. Lung inflammation in rats following subchronic exposure to cigarette mainstream smoke. Exp. Lung Res. 2006, 32:151-179.
36. Garibaldi J.A., Greenlaw J., Choi J., Fotovatjah M. Treatment of post-operative pain. J. Calif. Dent. Assoc. 1995, 23(71-72):74.
37. Gaworski C.L., Lemus-Olalde R., Carmines E.L. Toxicological evaluation of potassium sorbate added to cigarette tobacco. Food Chem. Toxicol. 2008, 46:339-351.
38. Gaworski C.L., Oldham M.J., Wagner K.A., Coggins C.R., Patskan G.J. An evaluation of the toxicity of 95 ingredients added individually to experimental cigarettes: approach and methods. Inhal. Toxicol. 2011, 23(Suppl. 1):1-12.
39. Guenette S.A., Beaudry F., Marier J.F., Vachon P. Pharmacokinetics and anesthetic activity of eugenol in male Sprague-Dawley rats. J. Vet. Pharmacol. Ther. 2006, 29:265-270.
40. Guidotti T.L. Possible risks to health associated with clove cigarettes. Chronic Dis. Can. 1985, 6:3-6.
41. Guidotti T.L. Critique of available studies on the toxicology of kretek smoke and its constituents by routes of entry involving the respiratory tract. Arch. Toxicol. 1989, 63:7-12.
42. Guidotti T.L., Binder S., Stratton J.W., Schechter F.G., Jenkins R.A. Clove cigarettes: development of a fad and evidence for health effects. Curr. Top. Pulm. Pharm. Toxicol. 1987, 2:1-23.
43. Guidotti T.L., Laing L., Prakash U.B. Clove cigarettes. The basis for concern regarding health effects. West. J. Med. 1989, 151:220-228.
44. Hackett P.H., Rodriguez G., Roach R.C. Clove cigarettes and high-altitude pulmonary edema. JAMA 1985, 253:3551-3552.
45. Health Canada, 1999. Determination of "tar", nicotine and carbon monoxide in mainstream smoke. In: Health Canada - Official Method.
46. Hemaiswarya S., Doble M. Synergistic interaction of eugenol with antibiotics against Gram negative bacteria. Phytomedicine 2009, 16:997-1005.
47. IARC Tobacco Smoking. International Agency for Research on Cancer, Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans 1985, vol. 38. Lyon, France.
48. ISO International Standard ISO 3308, Routine Analytical Cigarette-Smoking Machine - Definitions and Standard Conditions 1991, International Organization for Standardization, Geneva, Switzerland.
49. ISO International Standard ISO 4387, Determination of Total and Nicotine-free Dry Particulate Matter using Routine Analytical Smoking Machine 1991, International Organization for Standardization, Geneva, Switzerland.
50. ISO International Standard ISO 3402, Tobacco and Tobacco Products - Atmosphere for Conditioning and Testing 1999, International Organization for Standardization, Geneva, Switzerland.
51. Jirovetz L., Buchbauer G., Stoilova I., Stoyanova A., Krastanov A., Schmidt E. Chemical composition and antioxidant properties of clove leaf essential oil. J. Agric. Food Chem. 2006, 54:6303-6307.
52. Lamb D., Reid L. Goblet cell increase in rat bronchial epithelium after exposure to cigarette and cigar tobacco smoke. Br. Med. J. 1969, 1:33-35.
53. LaVoie E.J., Adams J.D., Reinhardt J., Rivenson A., Hoffmann D. Toxicity studies on clove cigarette smoke and constituents of clove: determination of the LD50 of eugenol by intratracheal instillation in rats and hamsters. Arch. Toxicol. 1986, 59:78-81.
54. Lee M.H., Yeon K.Y., Park C.K., Li H.Y., Fang Z., Kim M.S., Choi S.Y., Lee S.J., Lee S., Park K., Lee J.H., Kim J.S., Oh S.B. Eugenol inhibits calcium currents in dental afferent neurons. J. Dent. Res. 2005, 84:848-851.
55. Lemus R., Carmines E.L., Van Miert E., Coggins C.R., Anskeit E., Gerstenberg B., Meisgen T.J., Schramke H., Stabbert R., Volkel H., Terpstra P.M. Toxicological comparisons of cigarettes containing different amounts of vanillin. Inhal. Toxicol. 2007, 19:683-699.
56. Lewis D.J. Mitotic indices of rat laryngeal epithelia. J. Anat. 1981, 132:419-428.
57. Malson J.L., Lee E.M., Murty R., Moolchan E.T., Pickworth W.B. Clove cigarette smoking: biochemical, physiological, and subjective effects. Pharmacol. Biochem. Behav. 2003, 74:739-745.
58. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 1959, 22:719-748.
59. Markowitz K., Moynihan M., Liu M., Kim S. Biologic properties of eugenol and zinc oxide-eugenol. A clinically oriented review. Oral Surg. Oral Med. Oral Pathol. 1992, 73:729-737.
60. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 1983, 113:173-215.
61. Miller E.C., Swanson A.B., Phillips D.H., Fletcher T.L., Liem A., Miller J.A. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 1983, 43:1124-1134.
62. Miller E.G., Washington V.H., Bowles W.H., Zimmermann E.R. Mutagenic potential of some chemical components of dental materials. Dent. Mater. 1986, 2:163-165.
63. Moennikes O., Vanscheeuwijck P.M., Friedrichs B., Anskeit E., Patskan G.J. Reduced toxicological activity of cigarette smoke by the addition of ammonia magnesium phosphate to the paper of an electrically heated cigarette: subchronic inhalation toxicology. Inhal. Toxicol. 2008, 20:647-663.
64. Musenga A., Ferranti A., Saracino M.A., Fanali S., Raggl M.A. Simultaneous determination of aromatic and terpenic constituents of cloves by means of HPLC with diode array detection. J. Sep. Sci. 2006, 29:1251-1258.
65. Myhr B.C., Caspary W.J. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program. Environ. Mol. Mutagen. 1991, 18:51-83.
66. NTP, 1983. Toxicology and carcinogenesis studies of eugenol (CAS no. 97-53-0) in F344/N rats and B6C3F1 mice (feed studies). NTP-TR 223 http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr223.pdf.
67. O'Connor R.J. Non-cigarette tobacco products: what have we learnt and where are we headed?. Tob. Control 2012, 21:181-190.
68. OECD OECD Guideline 413, Subchronic Inhalation Study: 90-day Study 1981, Organisation for Economic Cooperation and Development, Paris.
69. OECD OECD Guideline 471, Bacterial Reverse Mutation Test 1997, Organization for Economic Cooperation and Development, Paris, France.
70. OECD OECD Guideline 476, In Vitro Mammalian Cell Gene Mutation Test 1997, Organization for Economic Cooperation and Development, Paris, France.
71. Oldham M.J., Haussmann H.J., Gomm W., Rimmer L.T., Morton M.J., McKinney W.J. Discriminatory power of standard toxicity assays used to evaluate ingredients added to cigarettes. Regul. Toxicol. Pharmacol. 2012, 62:49-61.
72. Park S.H., Sim Y.B., Lee J.K., Kim S.M., Kang Y.J., Jung J.S., Suh H.W. The analgesic effects and mechanisms of orally administered eugenol. Arch. Pharm. Res. 2011, 34:501-507.
73. Patskan G.J., Podraza K.F., Meurrens K., Coggins C.R., Friedrichs B., Gerstenberg B., Gomm W., Schnell P., Stabbert R., Veltel D., Weber S., Terpstra P. Toxicological comparisons of three styles of a commercial U.S. cigarette (Marlboro with the 1R4F reference cigarette. Inhal. Toxicol. 2008, 20:695-721.
74. Piadé, J.-J., Roemer, E., Dempsey, R., Hornig, G., Deger Evans, A., Völkel, H., Schramke, H., Trelles-Sticken, E., Wittke, S., Weber, S., Schorp, M.K., 2014a. Toxicological assessment of kretek cigarettes. Part 2: Kreteks and American-blend cigarettes, smoke chemistry and in vitro toxicity. Regul. Toxicol. Pharmacol. 70, S15-S25.
75. Piadé, J.-J., Roemer, E., Dempsey, R., Weiler, H., Meurrens, K., Vanscheeuwijck, P., Schorp, M.K., 2014b. Toxicological Assessment of Kretek Cigarettes. Part 3: Kreteks and American-blend cigarettes, Inhalation Toxicity. Regul. Toxicol. Pharmacol. 70, S26-S40.
76. Polzin G.M., Stanfill S.B., Brown C.R., Ashley D.L., Watson C.H. Determination of eugenol, anethole, and coumarin in the mainstream cigarette smoke of Indonesian clove cigarettes. Food Chem. Toxicol. 2007, 45:1948-1953.
77. Pramod K., Ansari S.H., Ali J. Eugenol: a natural compound with versatile pharmacological actions. Nat. Prod. Commun. 2010, 5:1999-2006.
78. Prignot J.J., Sasco A.J., Poulet E., Gupta P.C., Aditama T.Y. Alternative forms of tobacco use. Int. J. Tuberc. Lung Dis. 2008, 12:718-727.
79. Putnam K.P., Bombick D.W., Avalos J.T., Doolittle D.J. Comparison of the cytotoxic and mutagenic potential of liquid smoke food flavourings, cigarette smoke condensate and wood smoke condensate. Food Chem. Toxicol. 1999, 37:1113-1118.
80. Queiroz A.M., Nelson-Filho P., Silva L.A., Assed S., Silva R.A., Ito I.Y. Antibacterial activity of root canal filling materials for primary teeth: zinc oxide and eugenol cement, Calen paste thickened with zinc oxide, Sealapex and EndoREZ. Braz. Dent. J. 2009, 20:290-296.
81. Radtke, F., Schmickler, M., Ochel, W., Schaffernicht, H., 2007. Pumpenanordnung. In: Office, E.P., (Ed.), Germany.
82. Rickert W.S., Trivedi A.H., Momin R.A., Wagstaff W.G., Lauterbach J.H. Mutagenic, cytotoxic, and genotoxic properties of tobacco smoke produced by cigarillos available on the Canadian market. Regul. Toxicol. Pharmacol. 2011, 61:199-209.
83. Rickert W.S., Wright W.G., Trivedi A.H., Momin R.A., Lauterbach J.H. A comparative study of the mutagenicity of various types of tobacco products. Regul. Toxicol. Pharmacol. 2007, 48:320-330.
84. Rodrigues T.G., Fernandes A., Sousa J.P., Bastos J.K., Sforcin J.M. In vitro and in vivo effects of clove on pro-inflammatory cytokines production by macrophages. Nat. Prod. Res. 2009, 23:319-326.
85. Roemer E., Carchman R.A. Limitations of cigarette machine smoking regimens. Toxicol. Lett. 2011, 203:20-27.
86. Roemer, E., Dempsey, R., Hirter, J., Deger Evans, A., Weber, S., Ode, A., Wittke, S., Schorp, M.K., 2014a. Toxicological assessment of kretek cigarettes. Part 6: The impact of ingredients added to kretek cigarettes on the smoke chemistry and in vitro toxicity. Regul. Toxicol. Pharmacol. 70, S66-S80.
87. Roemer, E., Dempsey, R., Lawless-Pyne, J., Lukman, S., Deger Evans, A., Trelles-Sticken, E., Wittke, S., Schorp, M.K., 2014b. Toxicological assessment of kretek cigarettes. Part 4: mechanistic investigations, smoke chemistry and in vitro toxicity. Regul. Toxicol. Pharmacol. 70, S41-S53.
88. Roemer E., Ottmueller T.H., Zenzen V., Wittke S., Radtke F., Blanco I., Carchman R.A. Cytotoxicity, mutagenicity, and tumorigenicity of mainstream smoke from three reference cigarettes machine-smoked to the same yields of total particulate matter per cigarette. Food Chem. Toxicol. 2009, 47:1810-1818.
89. Roemer, E., Dempsey, R, Van Overveld, F.J., Berges, A., Pype, J., Weiler, H., Vanscheeuwijck, P., Schorp, M.K., 2014c. Toxicological Assessment of Kretek Cigarettes. Part 5: Mechanistic investigations, Inhalation Toxicity. Regul. Toxicol. Pharmacol. 70, S54-S65.
90. Roemer E., Schramke C., Weiler H., Buettner A., Kausche S., Weber S., Berges A., Stueber M., Muench M., Trelles-Sticken E., Pype J., Kohlgrueber K., Voelkel H., Wittke S. Mainstream smoke chemistry and in vitro and in vivo toxicity of the reference cigarette 3R4F and 2R4F. Beitr. Tabakforsch. Int. 2012, 25:316-335.
91. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R.A., Gaworski C.L., Podraza K.F. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 2004, 195:31-52.
92. Roemer E., Stabbert R., Veltel D., Muller B.P., Meisgen T.J., Schramke H., Anskeit E., Elves R.G., Fournier J.A. Reduced toxicological activity of cigarette smoke by the addition of ammonium magnesium phosphate to the paper of an electrically heated cigarette: smoke chemistry and in vitro cytotoxicity and genotoxicity. Toxicol. In Vitro 2008, 22:671-681.
93. Roemer E., Wittke S., Trelles Sticken E., Piade J.-J., Bonk T., Schorp M.K. The addition of cocoa, glycerol, and saccharose to the tobacco of cigarettes: implications for smoke chemistry, in vitro cytotoxicity, mutagenicity, anf further endpoints. Beitr. Tabakforsch. Int. 2010, 24:117-132.
94. Romagna F., Staniforth C.D. The automated bone marrow micronucleus test. Mutat. Res. 1989, 213:91-104.
95. Rustemeier K., Demetriou D., Schepers G., Voncken P. High-performance liquid chromatographic determination of nicotine and its urinary metabolites via their 1,3-diethyl-2-thiobarbituric acid derivatives. J. Chromatogr. 1993, 613:95-103.
96. Sagartz J.W., Madarasz A.J., Forsell M.A., Burger G.T., Ayres P.H., Coggins C.R. Histological sectioning of the rodent larynx for inhalation toxicity testing. Toxicol. Pathol. 1992, 20:118-121.
97. Schramke H., Meisgen T.J., Tewes F.J., Gomm W., Roemer E. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 2006, 227:193-210.
98. Schramke, H., Roemer, E., Dempsey, R., Hirter, J., Meurrens, K., Berges, A., Weiler, H., Vanscheeuwijck, P., Schorp, M.K., 2014. Toxicological assessment of kretek cigarettes. Part 7: The impact of ingredients added to kretek cigarettes on inhalation toxicity. Regul. Toxicol. Pharmacol. 70, S81-S89.
99. Sell A.B., Carlini E.A. Anesthetic action of methyleugenol and other eugenol derivatives. Pharmacology 1976, 14:367-377.
100. Stabbert R., Schafer K.H., Biefel C., Rustemeier K. Analysis of aromatic amines in cigarette smoke. Rapid Commun. Mass Spectrom. 2003, 17:2125-2132.
101. Stanfill S.B., Calafat A.M., Brown C.R., Polzin G.M., Chiang J.M., Watson C.H., Ashley D.L. Concentrations of nine alkenylbenzenes, coumarin, piperonal and pulegone in Indian bidi cigarette tobacco. Food Chem. Toxicol. 2003, 41:303-317.
102. Stich H.F., Rosin M.P., Wu C.H., Powrie W.D. The action of transition metals on the genotoxicity of simple phenols, phenolic acids and cinnamic acids. Cancer Lett. 1981, 14:251-260.
103. Sukumaran K., Kuttan R. Inhibition of tobacco-induced mutagenesis by eugenol and plant extracts. Mutat. Res. 1995, 343:25-30.
104. Tennant R.W., Margolin B.H., Shelby M.D., Zeiger E., Haseman J.K., Spalding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., et al. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 1987, 236:933-941.
105. US-CPSC, 1993, US Consumer Product Safety Commission: Toxicity Testing Plan for Low Ignition-Potential Cigarettes, vol. 3, Washington DC.
106. Van Miert E., Vanscheeuwijck P., Meurrens K., Gomm W., Terpstra P.M. Evaluation of the micronucleus assay in bone marrow and peripheral blood of rats for the determination of cigarette mainstream-smoke activity. Mutat. Res. 2008, 652:131-138.
107. Vanscheeuwijck P.M., Teredesai A., Terpstra P.M., Verbeeck J., Kuhl P., Gerstenberg B., Gebel S., Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food Chem. Toxicol. 2002, 40:113-131.
108. Wagner K.A., Finkel N.H., Fossett J.E., Gillman I.G. Development of a quantitative method for the analysis of tobacco-specific nitrosamines in mainstream cigarette smoke using isotope dilution liquid chromatography/electrospray ionization tandem mass spectrometry. Anal. Chem. 2005, 77:1001-1006.
109. Werley M.S., Freelin S.A., Wrenn S.E., Gerstenberg B., Roemer E., Schramke H., Van Miert E., Vanscheeuwijck P., Weber S., Coggins C.R. Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K. Regul. Toxicol. Pharmacol. 2008, 52:122-139.
110. WHO, 2009. WHO Indonesia, Tobacco Free Initiative, Country Situation. Available at http://ino.searo.who.int/EN/Section4/Section22_64.htm.
111. WHO, 2013. World Health Organization, Report on the global tobacco epidemic, 2013. Available at http://www.who.int/tobacco/surveillance/policy/country_profile/idn.pdf.
112. Yogalakshmi B., Viswanathan P., Anuradha C.V. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 2010, 268:204-212.
113. Young J.T. Histopathologic examination of the rat nasal cavity. Fundam. Appl. Toxicol. 1981, 1:309-312.
114. Yulisman, L., 2012. Brazil bans sale of clove cigarettes (to be retrieved at ) In: The Jakarta Post Jakarta. http://www.thejakartapost.com/news/2012/04/13/brazil-bans-sale-clove-cigarettes.html.
115. Zar J.H. Biostatistical Analysis 1999, Prentice Hall, New Jersey, USA.
116. Zenzen V., Diekmann J., Gerstenberg B., Weber S., Wittke S., Schorp M.K. Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 2: Smoke chemistry and in vitro toxicological evaluation using smoking regimens reflecting human puffing behavior. Regul. Toxicol. Pharmacol. 2012, 64:S11-34.